Literature DB >> 17354101

BM stem cell transplantation rescues pathophysiologic features of aged dystrophic mdx muscle.

M Yu1, C Zhang, Y Zhang, S Feng, X Yao, X Lu.   

Abstract

BACKGROUND: The value of transplantation of BM stem cells in aged (12-month-old) mdx was evaluated because it is thought to be a more ideal model for studying the praxiology of Duchenne muscular dystrophy (DMD). The possible mechanisms of stem cell differentiation were then discussed.
METHODS: BM was isolated from 8-10-week-old male C57 BL/10 mice. After injecting BM cells into 12-month-old female mdx mice through the tail vein, the expression of dystrophin and MyoD was detected at different time points by immunofluorescence staining, RT-PCR and Western blot.
RESULTS: The C57 male mice donor-specific and Y-chromosome-specific sequence could be detected in all female aged mdx mice, implying the success of the transplantation. Expression of dystrophin and MyoD was detected and increased over time. DISCUSSION: BM cells were recruited to the muscle and partially restored specific pathophysiologic features of the dystrophic muscle in aged mdx mice. Muscle differentiation of BM cells recapitulated embryonic myogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354101     DOI: 10.1080/14653240601114815

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  3 in total

1.  Activation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice.

Authors:  Yan-Chang Shang; Shu-Hui Wang; Fu Xiong; Fu-Ning Peng; Zhen-Shan Liu; Jia Geng; Cheng Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

2.  Improvement of contraction force in injured skeletal muscle after autologous mesenchymal stroma cell transplantation is accompanied by slow to fast fiber type shift.

Authors:  Philipp von Roth; Tobias Winkler; Kristina Rechenbach; Piotr Radojewski; Carsten Perka; Georg N Duda
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

3.  Skeletal Muscle-derived Hematopoietic Stem Cells: Muscular Dystrophy Therapy by Bone Marrow Transplantation.

Authors:  Atsushi Asakura
Journal:  J Stem Cell Res Ther       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.